GL-V9 is an AMPK activator, protecting against colitis-associated colorectal cancer by limiting NLRP3 inflammasome through autophagy. References: Yang L, He Z, Yao J, Tan R, Zhu Y, Li Z, Guo Q, Wei L. Regulation of AMPK-related glycolipid metabolism imbalances redox homeostasis and inhibits anchorage independent growth in human breast cancer cells. Redox Biol. 2018 Jul;17:180-191. doi: 10.1016/j.redox.2018.04.016. Epub 2018 Apr 18. PubMed PMID: 29702405; PubMed Central PMCID: PMC6006728.

纯度：≥98%

CAS：1178583-19-1